Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now reflects an updated ClinicalTrials.gov interface revision (v3.5.3) and the related generic topic/link section text was refreshed (with “Melanoma”/“related topics” and a prior revision reference removed). This represents a platform/content wrapper update rather than a change to the study record itself.
    Difference
    0.2%
    Check dated 2026-04-24T06:01:47.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Melanoma and MedlinePlus Genetics as related topics; updated page revision from v3.5.0 to v3.5.2.
    Difference
    0.2%
    Check dated 2026-04-17T02:35:10.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Melanoma-related topics and the MedlinePlus Genetics related links were removed from the page's related topics section.
    Difference
    0.2%
    Check dated 2026-03-26T11:19:11.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added Melanoma and related topics, including MedlinePlus Genetics, and updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T21:19:52.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    - Revision metadata updated: added Revision: v3.4.3. The Melanoma label and the MedlinePlus Genetics topic were removed, and Revision: v3.4.2 was deleted.
    Difference
    0.2%
    Check dated 2026-03-11T18:12:33.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as a related topic on the page.
    Difference
    0.2%
    Check dated 2026-03-04T14:20:51.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.